AAOS2019: Assessing the impact of celecoxib on tendon healing after arthroscopic rotator cuff repair
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
79 patients scheduled for an arthroscopic rotator cuff repair were randomized to receive pre- and postoperative celecoxib or placebo for 3 weeks. The outcome of interest was healing rate, and follow up was performed at 1 year. The findings from the study found no significant differences in healing rate between the celecoxib and placebo groups, despite a difference in healing rate of 19.4%. Readers...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.